Share on StockTwits

Equities researchers at UBS AG reduced their target price on shares of AMN Healthcare Services (NYSE:AHS) from $14.50 to $13.50 in a research report issued on Friday, Analyst Ratings Network reports. UBS AG’s price target points to a potential upside of 7.14% from the company’s current price.

Separately, analysts at BMO Capital Markets cut their price target on shares of AMN Healthcare Services from $17.00 to $15.00 in a research note on Friday. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. AMN Healthcare Services has a consensus rating of “Buy” and a consensus target price of $13.71.

Shares of AMN Healthcare Services (NYSE:AHS) traded down 10.71% during mid-day trading on Friday, hitting $11.25. 1,278,272 shares of the company’s stock traded hands. AMN Healthcare Services has a 52-week low of $11.00 and a 52-week high of $16.20. The stock has a 50-day moving average of $13.32 and a 200-day moving average of $13.85. The company has a market cap of $521.5 million and a price-to-earnings ratio of 18.26.

AMN Healthcare Services (NYSE:AHS) last released its earnings data on Thursday, May 1st. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.01. The company had revenue of $240.90 million for the quarter, compared to the consensus estimate of $246.80 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was down 4.4% on a year-over-year basis. Analysts expect that AMN Healthcare Services will post $0.73 EPS for the current fiscal year.

AMN Healthcare Services, Inc (NYSE:AHS) is a provider of healthcare staffing and clinical workforce management solutions, providing managed services and recruitment and placement of physicians, nurses and allied healthcare professionals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.